PMVP Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $1.79

Capitalizzazione di Mercato (MRQ) $96M

P/E -1.2

EPS $-1.48

ROE -63.4%

Intervallo 52 sett. $1–$2

PMVP Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

EPS$-1.48

2020-12-31 → 2025-12-31

Flusso di cassa libero$-74M

2020-12-31 → 2025-12-31

Margine netto-1226.8%

2020-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	PMVP	media 5 anni	Mediana dei peer	Verdetto
P/E	-1.2media 5 anni ≈-5.6	≈-5.6	·	·
P/S	15.1media 5 anni ≈495.9	≈495.9	73.7	Sottovalutato
P/B (MRQ)	1.3media 5 anni ≈1.4	≈1.4	2.5	Sottovalutato
Prezzo / FCF (TTM)	-1.3media 5 anni ≈-6.5	≈-6.5	·	·
Prezzo / Flusso di cassa (TTM)	-1.3media 5 anni ≈-6.8	≈-6.8	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	0.9media 5 anni ≈1.4	≈1.4	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	PMVP	media 5 anni	Mediana dei peer	Verdetto
Operating Margin (Margine Operativo)	-1360.4%media 5 anni ≈-3597.3%	≈-3597.3%	-3199.0%	Di prim'ordine
EBITDA Margin (Margine EBITDA)	-1360.4%media 5 anni ≈-3597.3%	≈-3597.3%	-3199.0%	Di prim'ordine
Pretax Margin (Margine ante imposte)	-1261.1%media 5 anni ≈-3496.1%	≈-3496.1%	-2294.8%	In linea
Net Profit Margin (Margine di Profitto Netto)	-1226.8%media 5 anni ≈-3460.0%	≈-3460.0%	-2452.9%	In linea
ROA	-50.5%media 5 anni ≈-28.9%	≈-28.9%	-57.6%	In linea
ROE	-63.4%media 5 anni ≈-34.3%	≈-34.3%	-63.4%	In linea
ROIC	-80.1%media 5 anni ≈-40.8%	≈-40.8%	-68.6%	Sotto la media

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	PMVP	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		7.7media 5 anni ≈16.9	≈16.9	7.7	In linea
Quick Ratio		9.9media 5 anni ≈16.5	≈16.5	7.5	In linea

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	PMVP	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-40.5%media 5 anni ≈167.9%	≈167.9%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	20.4%media 5 anni ≈121.9%	≈121.9%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	57.6%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	PMVP	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-1.48media 5 anni ≈$-1.39	≈$-1.39	·	·
Revenue / Share (Ricavi / Azione)	$0.12media 5 anni ≈$0.16	≈$0.16	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-1.40media 5 anni ≈$-1.24	≈$-1.24	·	·
Cash / Share (Liquidità / Azione)	$0.71media 5 anni ≈$1.68	≈$1.68	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	Tendenza 5 anni	PMVP	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)		0.0media 5 anni ≈0.0	≈0.0	0.0	Di prim'ordine

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 9.8%

Prossimo report Nov 10, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 14, 2026	$-0.34	$-0.40	14.0%
31 Marzo 2026	Mag 8, 2026	$-0.34	$-0.42	18.7%
31 Dicembre 2025		$-0.34	$-0.41	17.7%
30 Settembre 2025		$-0.40	$-0.41	2.6%
30 Giugno 2025		$-0.41	$-0.39	-4.9%
31 Marzo 2025		$-0.34	$-0.38	11.0%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 13

Metrica	2025	2024	2023	2022	2021	2020	2019
R&D Expense	$70M	$59M	$56M	$52M	$36M	$24M	$21M
SG&A Expense	$16M	$27M	$24M	$25M	$22M	$11M	$6M
Operating Expenses	$86M	$85M	$80M	$77M	$58M	$35M	$27M
Operating Income	$-86M	$-85M	$-80M	$-77M	$-58M	$-35M	$-27M
Other Non-op	$6M	$11M	$11M	$4M	$470.0K	$508.0K	$1M
Pretax Income	$-80M	$-75M	$-69M	$-73M	$-58M	$-34M	$-25M
Income Tax	$-2M	$-16M	$2.0K	$-9.0K	$23.0K	$6.0K	$8.0K
Net Income	$-78M	$-59M	$-69M	$-73M	$-58M	$-34M	$-25M
EPS (Basic)	$-1.48	$-1.14	$-1.44	$-1.61	$-1.28	$-2.40	·
EPS (Diluted)	$-1.48	$-1.14	$-1.44	$-1.61	$-1.28	$-2.40	·
Shares (Basic)	52,541,613	51,578,807	48,014,645	45,594,824	45,137,656	14,364,475	·
Shares (Diluted)	52,541,613	51,578,807	48,014,645	45,594,824	45,137,656	14,364,475	·
EBITDA	$-86M	$-85M	$-80M	$-77M	$-58M	$-35M	·

Stato Patrimoniale 20

Metrica	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$38M	$41M	$38M	$108M	$172M	$361M	$73M
Short-term Investments	$75M	$129M	$165M	$133M	$125M	·	·
Prepaid Expense	$2M	$6M	$4M	$5M	$3M	$3M	$607.0K
Current Assets	$115M	$176M	$207M	$247M	$301M	$365M	$102M
PP&E (Net)	$237.0K	$409.0K	$11M	$11M	$3M	$569.0K	$739.0K
PP&E (Gross)	$2M	$2M	$14M	$13M	$5M	$2M	$2M
Accum. Depreciation	$1M	$1M	$3M	$2M	$2M	$2M	$1M
Other Non-current Assets	$297.0K	$235.0K	$190.0K	$313.0K	$221.0K	$201.0K	$201.0K
Total Assets	$117M	$191M	$252M	$270M	$332M	$366M	$103M
Accounts Payable	$3M	$7M	$3M	$3M	$3M	$2M	$3M
Accrued Liabilities	$8M	$7M	$10M	$7M	$9M	$5M	$2M
Current Liabilities	$11M	$14M	$14M	$11M	$12M	$6M	$5M
Capital Leases	$435.0K	$838.0K	$12M	$13M	$11M	·	·
Other Non-current Liabilities	·	·	·	·	·	·	$51.0K
Total Liabilities	$12M	$15M	$26M	$24M	$23M	$6M	$5M
Retained Earnings	$-446M	$-369M	$-310M	$-241M	$-168M	$-110M	$-75M
AOCI	$84.0K	$139.0K	$224.0K	$-445.0K	$-78.0K	·	$-3.0K
Stockholders' Equity	$105M	$176M	$226M	$246M	$309M	$359M	$-70M
Liabilities + Equity	$117M	$191M	$252M	$270M	$332M	$366M	$103M
Shares Outstanding	53,331,766	51,935,134	51,445,862	45,771,332	45,433,684	44,777,818	3,046,200

Flusso di cassa 10

Metrica	2025	2024	2023	2022	2021	2020	2019
Stock-based Comp	$6M	$9M	$12M	$10M	$5M	$2M	$908.0K
Operating Cash Flow	$-74M	$-51M	$-56M	$-64M	$-47M	$-33M	$-22M
CapEx	$29.0K	$655.0K	$962.0K	$8M	$1M	$148.0K	$109.0K
Investing Cash Flow	$70M	$53M	$-51M	$-1M	$-144M	$28M	$3M
Stock Issued	·	·	$35M	·	·	$223M	·
Net Stock Activity	·	·	$35M	·	·	$223M	·
Financing Cash Flow	$505.0K	$313.0K	$36M	$958.0K	$2M	$293M	$62M
Net Change in Cash	$-3M	$2M	$-71M	$-64M	$-188M	$288M	$43M
Taxes Paid	·	·	·	·	$23.0K	$6.0K	$8.0K
Free Cash Flow	$-74M	$-52M	$-57M	$-72M	$-48M	$-33M	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-1360.4%	-802.0%	-717.3%	-2124.1%	-12982.8%	-5367.4%	·
Net Margin	-1226.8%	-551.0%	-617.3%	-2021.4%	-12883.3%	-5290.3%	·
Pretax Margin	-1261.1%	-702.1%	-617.3%	-2021.7%	-12878.2%	-5289.4%	·
EBITDA Margin	-1360.4%	-802.0%	-717.3%	-2124.1%	-12982.8%	-5367.4%	·
ROA	-50.5%	-26.5%	-26.4%	-24.4%	-16.6%	-14.7%	·
ROE	-63.4%	-31.4%	-29.8%	-28.9%	-18.3%	-9.5%	·
ROIC	-80.1%	-38.1%	-35.5%	-31.3%	-18.9%	-9.7%	·

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019
Current Ratio		10.1	12.2	14.8	22.8	24.7	56.9	·
Quick Ratio		9.9	11.8	14.5	22.3	24.3	56.4	·

Efficienza 1

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.0	0.0	0.0	0.0	0.0	0.0	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$1.96	$3.39	$4.39	$5.38	$6.79	$8.02	·
Revenue / Share	$0.12	$0.21	$0.23	$0.08	·	·	·
Cash Flow / Share	$-1.40	$-0.99	$-1.16	$-1.40	·	·	·
Cash / Share	$0.71	$0.79	$0.73	$2.37	$3.80	$8.07	·
EPS (TTM)	$-1.48	$-1.14	$-1.44	$-1.61	$-1.28	$-2.40	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	-40.5%	-4.6%	208.0%	707.8%	-31.0%	·	·
Revenue CAGR 3Y	20.4%	187.4%	157.9%	·	·	·	·
Revenue CAGR 5Y	57.6%	·	·	·	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$6M	$11M	$11M	$4M	$449.0K	$651.0K	·
Net Income TTM	$-78M	$-59M	$-69M	$-73M	$-58M	$-34M	·
Market Cap	$67M	$78M	$159M	$398M	$1.05B	$2.75B	·
P/E	-0.8	-1.3	-2.2	-5.4	-18.0	-25.6	·
P/S	10.5	7.4	14.3	109.8	2337.5	4230.9	·
P/B	0.6	0.4	0.7	1.6	3.4	7.7	·
P / Tangible Book	0.6	0.4	0.7	1.6	3.4	7.7	·
P / Cash Flow	-0.9	-1.5	-2.9	-6.2	-22.5	-84.1	·
P / FCF	-0.9	-1.5	-2.8	-5.6	-21.9	-83.7	·
Earnings Yield	-118.4%	-75.5%	-46.5%	-18.5%	-5.5%	-3.9%	·

Conto Economico 13

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
R&D Expense	$15M	$15M	$16M	$18M	$18M	$17M	$14M	$17M	$15M	$13M	$14M	$14M	$15M	$14M	$11M	$12M
SG&A Expense	$4M	$4M	$3M	$4M	$4M	$4M	$11M	$5M	$6M	$5M	$6M	$6M	$6M	$6M	$6M	$7M
Operating Expenses	$19M	$19M	$19M	$23M	$23M	$22M	$25M	$22M	$20M	$18M	$20M	$20M	$21M	$19M	$18M	$19M
Operating Income	$-19M	$-19M	$-19M	$-23M	$-23M	$-22M	$-25M	$-22M	$-20M	$-18M	$-20M	$-20M	$-21M	$-19M	$-18M	$-19M
Other Non-op	$798.0K	$981.0K	$1M	$1M	$2M	$2M	$2M	$3M	$3M	$3M	$3M	$3M	$2M	$1M	$573.0K	$188.0K
Pretax Income	$-18M	$-18M	$-18M	$-21M	$-21M	$-20M	$-23M	$-19M	$-17M	$-15M	$-17M	$-17M	$-19M	$-18M	$-17M	$-18M
Income Tax	$3.0K	·	$26.0K	$-6.0K	$5.0K	$-2M	$0	$74.0K	$-16M	·	$-1.0K	$4.0K	·	$-9.0K	$-2.0K	$2.0K
Net Income	$-18M	$-18M	$-18M	$-21M	$-21M	$-17M	$-23M	$-19M	$-1M	$-15M	$-17M	$-17M	$-19M	$-18M	$-17M	$-18M
EPS (Basic)	$-0.34	$-0.34	$-0.33	$-0.40	$-0.41	$-0.34	$-0.45	$-0.37	$-0.02	$-0.30	$-0.34	$-0.38	$-0.42	$-0.40	$-0.38	$-0.41
EPS (Diluted)	$-0.34	$-0.34	$-0.33	$-0.40	$-0.41	$-0.34	$-0.45	$-0.37	$-0.02	$-0.30	$-0.34	$-0.38	$-0.42	$-0.40	$-0.38	$-0.41
Shares (Basic)	53,386,909	53,331,766	·	52,993,238	52,010,827	51,952,062	·	51,574,027	51,478,751	51,445,862	49,047,296	45,813,132	45,773,357	45,622,957	45,571,067	45,466,044
Shares (Diluted)	53,386,909	53,331,766	·	52,993,238	52,010,827	51,952,062	·	51,574,027	51,478,751	51,445,862	49,047,296	45,813,132	45,773,357	45,622,957	45,571,067	45,466,044
EBITDA	$-19M	$-19M	·	$-23M	$-23M	$-22M	·	$-22M	$-20M	$-18M	$-20M	$-20M	$-21M	$-19M	$-18M	$-19M

Stato Patrimoniale 19

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$12M	$39M	$38M	$36M	$44M	$51M	$41M	$49M	$49M	$48M	$52M	$68M	$143M	$100M	$87M	$116M
Short-term Investments	$67M	$54M	$75M	$93M	$98M	$109M	$129M	$134M	$164M	$150M	$150M	$119M	$86M	$159M	$190M	$167M
Prepaid Expense	$2M	$2M	$2M	$3M	$3M	$3M	$6M	$6M	$5M	$4M	$3M	$3M	$3M	$5M	$4M	$4M
Current Assets	$81M	$96M	$115M	$132M	$145M	$163M	$176M	$190M	$219M	$202M	$205M	$190M	$233M	$265M	$282M	$288M
PP&E (Net)	$154.0K	$203.0K	$237.0K	$255.0K	$287.0K	$376.0K	$409.0K	$10M	$11M	$11M	$11M	$11M	$11M	$10M	$9M	$5M
PP&E (Gross)	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$14M	$15M	$15M	$14M	$14M	$14M	$12M	$11M	$7M
Accum. Depreciation	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$4M	$4M	$4M	$3M	$3M	$2M	$2M	$2M	$2M
Other Non-current Assets	$296.0K	$296.0K	$297.0K	$249.0K	$248.0K	$237.0K	$235.0K	$242.0K	$182.0K	$182.0K	$180.0K	$181.0K	$314.0K	$307.0K	$308.0K	$221.0K
Total Assets	$82M	$97M	$117M	$134M	$153M	$171M	$191M	$223M	$238M	$237M	$261M	$242M	$254M	$285M	$301M	$315M
Accounts Payable	$2M	$2M	$3M	$3M	$3M	$4M	$7M	$2M	$5M	$859.0K	$2M	$3M	$2M	$5M	$3M	$5M
Accrued Liabilities	$8M	$7M	$8M	$9M	$9M	$6M	$7M	$10M	$6M	$10M	$9M	$8M	$9M	$6M	$8M	$7M
Current Liabilities	$11M	$9M	$11M	$12M	$12M	$10M	$14M	$14M	$11M	$12M	$11M	$11M	$11M	$12M	$11M	$12M
Capital Leases	$0	$0	$435.0K	$541.0K	$643.0K	$742.0K	$838.0K	$12M	$12M	$12M	$13M	$13M	$13M	$12M	$12M	$11M
Total Liabilities	$11M	$9M	$12M	$13M	$12M	$11M	$15M	$26M	$23M	$24M	$23M	$24M	$24M	$24M	$24M	$23M
Retained Earnings	$-483M	$-464M	$-446M	$-428M	$-407M	$-386M	$-369M	$-346M	$-326M	$-325M	$-294M	$-278M	$-260M	$-222M	$-203M	$-186M
AOCI	$-82.0K	$-15.0K	$84.0K	$91.0K	$21.0K	$84.0K	$139.0K	$410.0K	$-185.0K	$-129.0K	$-355.0K	$-328.0K	$-116.0K	$-1M	$-1M	$-666.0K
Stockholders' Equity	$72M	$88M	$105M	$121M	$141M	$160M	$176M	$198M	$214M	$213M	$238M	$218M	$230M	$261M	$277M	$292M
Liabilities + Equity	$82M	$97M	$117M	$134M	$153M	$171M	$191M	$223M	$238M	$237M	$261M	$242M	$254M	$285M	$301M	$315M
Shares Outstanding	53,460,432	53,331,766	53,331,766	52,993,238	52,993,238	51,954,135	51,935,134	51,749,504	51,522,125	51,445,862	51,157,636	46,143,536	45,774,761	45,624,860	45,622,610	45,532,392

Flusso di cassa 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Stock-based Comp	$2M	$1M	$1M	$1M	$2M	$2M	$1M	$2M	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$2M
Operating Cash Flow	$-15M	$-20M	$-17M	$-20M	$-18M	$-18M	$-17M	$-17M	$-2M	$-16M	$-16M	$-13M	$-15M	$-17M	$-14M	$-18M
CapEx	$0	$0	$15.0K	$-1.0K	$11.0K	$4.0K	$56.0K	$1.0K	$4.0K	$594.0K	$44.0K	$565.0K	$156.0K	$2M	$4M	$796.0K
Investing Cash Flow	$-12M	$21M	$18M	$12M	$11M	$29M	$8M	$17M	$2M	$26M	$-34M	$-64M	$50M	$30M	$-15M	$-39M
Stock Issued	·	·	·	·	·	·	·	·	·	·	$33M	·	·	·	·	·
Financing Cash Flow	$143.0K	$0	$392.0K	$0	$103.0K	$10.0K	$172.0K	$0	$141.0K	$0	$33M	$2M	$12.0K	$6.0K	$276.0K	$128.0K
Net Change in Cash	$-27M	$1M	$2M	$-8M	$-7M	$10M	$-9M	$284.0K	$872.0K	$10M	$-16M	$-75M	$35M	$13M	$-29M	$-57M
Taxes Paid	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$2.0K
Free Cash Flow	·	$-20M	·	·	·	$-18M	·	·	·	$-17M	·	·	$-15M	·	·	$-19M

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Operating Margin	-2396.1%	-1940.7%	·	-1521.8%	-1353.8%	-1114.4%	·	-837.0%	-720.1%	-617.2%	-657.8%	-746.4%	-923.9%	-1723.8%	-2961.1%	-8130.6%
Net Margin	-2295.2%	-1840.6%	·	-1422.9%	-1255.0%	-901.1%	·	-735.2%	-43.3%	-517.3%	-557.6%	-646.7%	-822.7%	-1621.8%	-2865.9%	-8049.3%
Pretax Margin	-2294.8%	-1840.6%	·	-1423.3%	-1254.7%	-1014.6%	·	-732.4%	-620.7%	-517.3%	-557.6%	-646.6%	-822.7%	-1622.6%	-2866.2%	-8048.5%
EBITDA Margin	-2396.1%	-1940.7%	·	-1521.8%	-1353.8%	-1114.4%	·	-837.0%	-720.1%	-617.2%	-657.8%	-746.4%	-923.9%	-1723.8%	-2961.1%	-8130.6%
ROA	-15.4%	-13.5%	·	-11.8%	-10.9%	-8.6%	·	-7.9%	-0.51%	-5.5%	-6.5%	-6.4%	·	-5.8%	-5.3%	-5.5%
ROE	-17.1%	-14.5%	·	-13.2%	-11.9%	-9.3%	·	-8.8%	-0.56%	-6.0%	-7.1%	-7.0%	·	-6.2%	-5.6%	-5.8%
ROIC	-26.4%	·	·	-18.6%	-16.3%	-12.0%	·	-11.1%	-0.66%	·	·	-9.2%	·	-7.4%	-6.5%	-6.4%

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio		7.7	11.1	·	10.8	12.5	16.8	·	14.0	19.2	16.8	19.2	16.6	·	22.8	24.8	24.7
Quick Ratio		7.5	10.9	·	10.5	12.3	16.4	·	13.5	18.7	16.4	18.8	16.3	·	22.2	24.4	24.2

Efficienza 1

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	0.0	0.0	·	0.0	0.0	0.0

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$1.34	$1.65	·	$2.28	$2.65	$3.08	·	$3.82	$4.16	$4.13	$4.64	$4.72	·	$5.72	$6.07	$6.41
Revenue / Share	$0.01	$0.02	·	$0.03	$0.03	$0.04	·	$0.05	$0.05	$0.06	$0.06	$0.06	$0.05	$0.02	·	·
Cash Flow / Share	·	$-0.37	·	·	·	$-0.35	·	·	·	$-0.31	·	·	$-0.33	·	·	·
Cash / Share	$0.23	$0.73	·	$0.69	$0.83	$0.99	·	$0.94	$0.94	$0.93	$1.02	$1.48	·	$2.19	$1.91	$2.54
EPS (TTM)	$-1.41	$-1.48	·	$-1.60	$-1.57	$-1.18	·	$-0.99	$-0.96	$-1.32	$-1.56	$-1.62	$-1.62	$-1.59	$-1.52	·

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	$4M	$5M	·	$7M	$9M	$10M	·	$12M	$12M	$12M	$10M	$8M	$6M	$2M	$1M	$550.0K
Net Income TTM	$-75M	$-78M	·	$-83M	$-81M	$-61M	·	$-51M	$-49M	$-65M	$-73M	$-74M	$-74M	$-72M	$-69M	$-65M
Market Cap	$72M	$66M	·	$74M	$56M	$57M	·	$77M	$83M	$87M	$314M	$289M	·	$543M	$650M	$948M
P/E	-1.0	-0.8	·	-0.9	-0.7	-0.9	·	-1.5	-1.7	-1.3	-3.9	-3.9	-2.9	-7.5	-9.4	·
P/S	16.0	12.3	·	10.0	6.6	5.9	·	6.7	7.0	7.4	32.5	37.0	·	263.2	624.5	1723.6
P/B	1.0	0.8	·	0.6	0.4	0.4	·	0.4	0.4	0.4	1.3	1.3	·	2.1	2.3	3.2
P / Tangible Book	1.0	0.8	·	0.6	0.4	0.4	·	0.4	0.4	0.4	1.3	1.3	·	2.1	2.3	3.2
P / Cash Flow	·	-3.4	·	·	·	-3.1	·	·	·	-5.4	·	·	·	·	·	-52.7
Earnings Yield	-105.2%	-119.3%	·	-114.3%	-148.1%	-108.3%	·	-66.4%	-59.3%	-77.6%	-25.4%	-25.9%	-34.0%	-13.4%	-10.7%	·

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Margine Operativo %	-1360.4%	-802.0%	-717.3%	-2124.1%	-12982.8%
Utile netto	$-78M	$-59M	$-69M	$-73M	$-58M
EPS Diluito	$-1.48	$-1.14	$-1.44	$-1.61	$-1.28

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	10.1	12.2	14.8	22.8	24.7
Quick Ratio	9.9	11.8	14.5	22.3	24.3

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-74M	$-52M	$-57M	$-72M	$-48M

Proprietari istituzionali (13F) 69 filer · $47.1M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 69

Valore detenuto $47.1M

Nuove posizioni 5

Posizioni chiuse 8

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
5 (-11 vs trimestre precedente)	8 (0 vs trimestre precedente)	15 (-2 vs trimestre precedente)	22 (+4 vs trimestre precedente)	-2.5M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BML Capital Management, LLC	$7.142.200	5.330.000	15,18%	Azioni
TANG CAPITAL MANAGEMENT LLC	$5.688.414	4.245.085	12,09%	Azioni
Sio Capital Management, LLC	$3.529.744	2.634.137	7,50%	Azioni
Euclidean Capital LLC	$3.521.042	2.627.643	7,48%	Azioni
ADAGE CAPITAL PARTNERS GP, L.L.C.	$3.162.400	2.360.000	6,72%	Azioni
VANGUARD GROUP INC	$2.712.888	2.170.310	5,77%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$2.696.107	2.012.020	5,73%	Azioni
ArrowMark Colorado Holdings LLC	$2.625.836	1.959.579	5,58%	Azioni
TWO SIGMA INVESTMENTS, LP	$2.618.542	1.954.136	5,56%	Azioni
Eversept Partners, LP	$2.533.811	1.890.904	5,38%	Azioni
BlackRock, Inc.	$1.232.556	919.818	2,62%	Azioni
TWO SIGMA ADVISERS, LP	$1.092.625	874.100	2,32%	Azioni
Stonepine Capital Management, LLC	$718.355	536.086	1,53%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$634.624	473.158	1,35%	Azioni
Aldebaran Capital, LLC	$626.359	467.432	1,33%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$574.663	428.853	1,22%	Azioni
BIT Capital GmbH	$546.124	407.555	1,16%	Azioni
Verdad Advisers, LP	$485.564	362.361	1,03%	Azioni
Walleye Capital LLC	$449.830	335.694	0,96%	Azioni
Assenagon Asset Management S.A.	$442.204	330.003	0,94%	Azioni
MARSHALL WACE, LLP	$430.956	321.610	0,92%	Azioni
VANGUARD FIDUCIARY TRUST CO	$341.399	254.775	0,73%	Azioni
BANK OF AMERICA CORP /DE/	$321.747	240.110	0,68%	Azioni
CITADEL ADVISORS LLC	$271.082	202.300	0,58%	Opzione Call
ADAR1 Capital Management, LLC	$269.351	201.008	0,57%	Azioni
STATE STREET CORP	$245.459	183.178	0,52%	Azioni
RBF Capital, LLC	$217.348	162.200	0,46%	Azioni
GOLDMAN SACHS GROUP INC	$183.572	136.994	0,39%	Azioni
MAI Capital Management	$178.383	133.122	0,38%	Azioni
Rangeley Capital, LLC	$132.982	99.240	0,28%	Azioni
NORTHERN TRUST CORP	$124.683	93.047	0,26%	Azioni
Ikarian Capital, LLC	$119.442	89.136	0,25%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$94.475	70.504	0,20%	Azioni
PNC Financial Services Group, Inc.	$91.038	67.938	0,19%	Azioni
Quadrature Capital Ltd	$83.174	62.070	0,18%	Azioni
Seven Fleet Capital Management LP	$71.782	53.569	0,15%	Azioni
CITADEL ADVISORS LLC	$63.393	47.308	0,13%	Azioni
Accurate Wealth Management, LLC	$62.000	50.000	0,13%	Azioni
Cubist Systematic Strategies, LLC	$61.417	43.869	0,13%	Azioni
MORGAN STANLEY	$55.856	41.684	0,12%	Azioni
JANE STREET GROUP, LLC	$53.878	40.207	0,11%	Azioni
ALGERT GLOBAL LLC	$53.403	39.853	0,11%	Azioni
COOPER/HAIMS ADVISORS, LLC	$52.288	39.021	0,11%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$50.292	37.531	0,11%	Azioni
Connor, Clark & Lunn Investment Management Ltd.	$43.496	32.460	0,09%	Azioni
Squarepoint Ops LLC	$42.656	31.833	0,09%	Azioni
HSBC HOLDINGS PLC	$40.776	30.891	0,09%	Azioni
BARCLAYS PLC	$37.201	27.761	0,08%	Azioni
BOOTHBAY FUND MANAGEMENT, LLC	$36.349	27.126	0,08%	Azioni
Vanguard Global Advisers, LLC	$28.889	21.559	0,06%	Azioni

Mostra tutti i 69 proprietari istituzionali →

Attivisti e proprietari del 5%+ 1 partecipazione

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×5 depositi	04 Marzo 2026	0,00%	Modifica	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 16 insider · 5 dirigenti · 9 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Netto 12m
Michael Carulli	Chief Financial Officer	05 Marzo 2026 A	60.146	$0
Winston Kung	COO, CFO	12 Maggio 2023 A	10.600	$0
Robert Ticktin	General Counsel & COO	05 Marzo 2026 A	98.695	$0
Deepika Jalota	Chief Development Officer	05 Marzo 2026 A	89.959	$0
Leila Alland	Chief Medical Officer	15 Settembre 2023 S	45.909	$0
Kirsten Flowers	Direttore	04 Giugno 2026 A	·	$0
Laurie Stelzer	Direttore	04 Giugno 2026 A	·	$0
Charles M Baum	Direttore	04 Giugno 2026 A	·	$0
Carol Giltner Gallagher	Direttore	04 Giugno 2026 G	·	$0
Arnold J Levine	Direttore	04 Giugno 2026 A	409.842	$0
Richard A. Heyman	Direttore	05 Giugno 2025 A	0	$0
Peter A. Thompson	Direttore	02 Giugno 2022 A	475.000	$0
Thilo Schroeder	Direttore	06 Ottobre 2021 S	1.101.283	$0
Arnold L Oronsky	Direttore	29 Settembre 2020 C	6.469.911	$0
David Henry Mack	·	05 Marzo 2026 A	451.109	$0
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.	·	29 Settembre 2020 C	760.267	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 3 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IWC · iShares Trust	0,02%	159.470 SH	11 Settembre 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,00%	452.363 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	1.487.065 SH	19 Agosto 2026	Giornaliero

PMVP Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 12 analisti COMPRA

Target mediano $4.00 +123,5%

4 33,3% Acquisto forte

7 58,3% Compra

1 8,3% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

5 analisti · 2026-09-29

Target medio $4.20 +134,6%

← Sotto tutti i target Prezzo attuale $1.79

Basso$3.00 Media$4.20 Alto$5.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
PMVP	$67M	-0.8	-40.5%	-1226.8%	-63.4%	·
ABOS	$128M	-1.1	·	·	-129.4%	·
HUMA	·	·	·	·	·	·
KRRO	$75M	-0.6	181.5%	-1834.5%	-140.8%	·
OTLK	$57M	-0.6	·	-4416.2%	193.1%	4.0%
RNA	$10.91B	-14.5	72.1%	-3650.4%	-47.5%	·
CRBU	$151M	-1.0	11.7%	-1327.4%	-102.8%	·
SPRB	$120M	-1.7	-51.3%	·	-139.9%	·
CBUS	·	-0.6	-14.6%	-3492.3%	-223.0%	·
TNYA	$154M	-1.2	·	·	-81.2%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

PMVP PMV Pharmaceuticals, Inc. - Common Stock

PMVP Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

PMVP Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Proprietari istituzionali (13F) 69 filer · $47.1M totale · Aggiornato al 30 Giugno 2026

Attivisti e proprietari del 5%+ 1 partecipazione

Insider aziendali 16 insider · 5 dirigenti · 9 direttori

Proprietà ETF Posseduti da 3 ETF

PMVP Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi